$XOMA

Sitko Bradley sold (to issuer) 2,082 shares of XOMA (indirect holdings)

Sitko Bradley (Chief Investment Officer) sold (to issuer) 2,082 indirectly-held shares of XOMA Royalty Corp (XOMA) across 2 trades on 2026-07-14.

Original reporting
SEC EDGAR · Sitko Bradley
Published Jul 15, 2026, 1:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 15, 2026, 2:00 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$XOMA
Neutral
high confidence
Mentioned
$XOMA
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$XOMANeutralLow
01

Why it matters

Insider selling can be sentiment-negative, but this filing provides no disclosed transaction price/value and no company-specific news (no guidance, trial, deal, or regulatory action).

02

Market read

Traders may note the insider sale, but it is unlikely to drive a material repricing without additional company catalysts.

03

What to watch

Because the price and total value are not disclosed and the holdings after transaction are 0, the signal is incomplete for assessing whether it was tax-related, liquidity-related, or tied to a specific plan.

Relevance 3/10Novelty 2/10Timing: filed 2026-07-14 after-hours on SEC EDGAR

Background

The article is an SEC Form 4 insider transaction disclosure for XOMA Royalty Corp, reported by Sitko Bradley (Chief Investment Officer) as an indirect holding sale to the issuer.

Company-level read

Ticker impact

$XOMANeutralHigh confidence
Context

SEC Form 4 shows CFO Sitko Bradley sold 2,082 shares of XOMA to the issuer on 2026-07-14, leaving 0 shares indirectly.

Expected impact

Likely minimal near-term impact; any effect is more sentiment/flow-related than fundamental.

Evidence & confidence

The filing is an insider transaction (Form 4) with small disclosed share count, no price/value, and no accompanying company event or guidance change.

Market effects

No sector read-through; this is an issuer buyback participation style Form 4 with no operational update.

None.

None.

Counterpoint

The sale is to the issuer and may be part of a pre-arranged or administrative mechanism, so it may not reflect bearish views.

Key entities

  • XOMA Royalty Corp

    Subject of the Form 4 insider transaction disclosure.

  • Sitko Bradley

    Chief Investment Officer who sold 2,082 shares to the issuer on 2026-07-14.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LGNDMedAI 9/10

XOMA Royalty Announces Closing of Its Acquisition by Ligand

XOMA Royalty said Ligand Pharmaceuticals (Nasdaq: LGND) completed its acquisition of XOMA Royalty. Under the April 27 deal, XOMA shareholders received $39.00 cash per share and one non-transferable CVR per share tied to 75% of net proceeds from certain pending litigation. XOMA shares no longer trade on Nasdaq.

$LAURMed

Snow Ian Kendell sold $19.1M of LAUR (indirect holdings)

Snow Ian Kendell sold 521,229 indirectly-held shares of LAUREATE EDUCATION, INC. (LAUR) at an average of $36.65 ($36.26–$38.43, $19.10M total) across 3 trades over 2026-08-31 to 2026-09-02. Filed jointly with Snow Phipps Group (RPV), L.P. (Director), Snow Phipps Group (Offshore), L.P. (Director), SPG Co-Investment, L.P. (Director), Snow Phipps Group (B), L.P. (Director), Snow Phipps Group, L.P. (Director) and Snow Phipps Group, LLC (Director).